Patent application number | Description | Published |
20090317484 | SALIVARY SUBSTITUTE - A salivary substitute is produced from egg white so as to have chemical, rheological and physiological properties that are analogous to those of natural human saliva. A packaging containing the salivary substitute and uses of the salivary substitute are also disclosed. | 12-24-2009 |
20100022496 | GALENICAL FORM FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS BY TRANSMUCOUS MEANS - A galenical form for the administration transmucously of at least one active ingredient, characterized in that the active ingredient is in a stable and complete dissolved state in a hydroalcoholic solution that includes at least 20% by mass of alcohol so as to allow rapid absorption of the active ingredient through the mucous membranes of the buccal cavity and/or the oropharynx. Uses of the galenical form are also disclosed. | 01-28-2010 |
20100093710 | GALENICAL FORM FOR THE ADMINISTRATION OF PARACETAMOL BY TRANSMUCOUS MEANS - A galenical form for the transmucous administration of at least one active ingredient, characterized in that the active ingredient is paracetamol in a stable and complete dissolved state in a hydroalcoholic solution that includes at least 10% by mass of alcohol so as to allow fast absorption of the active ingredient through the mucous membranes of the buccal cavity and/or the oropharynx. A process for production and the uses of the galenical form are also disclosed. | 04-15-2010 |
20100198147 | DEVICE FOR PACKAGING AND SUBLINGUAL ADMINISTRATION OF ACTIVE PRINCIPLES - The invention provides a container for preparing and/or administering a very small volume of active principles in liquid form, the container comprising a head ( | 08-05-2010 |
20100298401 | GALENICAL FORM FOR THE ADMINISTRATION OF TRIPTANS BY BUCCAL TRANSMUCOUS MEANS - The object of the invention is a galenical form for the administration by buccal transmucous means of at least one active ingredient of the triptan family, comprising at least:
| 11-25-2010 |
20110054437 | DEVICE FOR CONSERVING, EXTEMPORANEOUSLY PREPARING, AND ADMINISTERING AN ACTIVE PRINCIPLE - The invention provides a device ( | 03-03-2011 |
20110238008 | DEVICE FOR PACKAGING AND DELIVERING ACTIVE PRINCIPLES IN A HYDROALCOHOLIC SOLUTION - The invention provides a packaging and administering device for administering a hydro-alcoholic solution by passing through a mucous membrane, the device comprising a deformable container for receiving at least one first fraction of the solution, a base that is secured to the container, and an administering tube that is secured to the base and that is suitable for receiving at least one second fraction of the solution, and that includes a cap. The tube includes a chamber for containing the at least one second solution and that is defined by two membranes, and the cap is movable in translation between two extreme positions and includes a needle for coming to pierce the two membranes in one of the extreme positions. | 09-29-2011 |
20110251233 | FORMULATION FOR THE BUCCAL TRANSMUCOSAL ADMINISTRATION OF SETRONS - The invention provides a formulation for transmucosal administration of at least one active ingredient from the setron family, the formulation comprising said active ingredient in base form and/or in salt form, a hydroalcoholic solution titrating at least 30° alcohol, and optionally a pH correcting agent, said active principle being present in the state of stable and complete dissolution in the hydroalcoholic solution. The invention also provides a method of preparing this formulation and its use for the treatment and prevention of major nausea and/or vomiting syndromes, and also for the treatment and prevention of digestive spasms. | 10-13-2011 |
20110257149 | FORMULATION FOR ORAL TRANSMUCOSAL ADMINISTRATION OF LIPID-LOWERING DRUGS - The invention relates to a formulation for delivering by oral transmucosal administration at least one lipid-lowering active principle, preferably from the statin family, said formulation including said active principle in the base or salt form, an aqueous alcohol solution titrating at least 30° alcohol, and optionally a pH correcting agent and/or an antioxidant, said active principle being in a stable and completely dissolved state in the aqueous alcohol solution. The invention also relates to a method of preparing said formulation and to the use thereof, preferably in single-dose packaging, for treating and preventing hyperlipemia and/or cardiovascular conditions. | 10-20-2011 |
20110275626 | FORMULATION FOR ORAL TRANSMUCOSAL ADMINISTRATION OF ANALGESIC AND/OR ANTISPASMODIC MOLECULES - A formulation for oral transmucosal administration of at least one active principle with antispasmodic and/or analgesic effect, including the active principle in base form and/or in salt form, an aqueous alcohol solution titrating at least 35° alcohol by weight, the active principle being present in a state of stable and complete dissolution in the aqueous alcohol solution. Also, a method of preparing this formulation and its use for treating spastic crises. | 11-10-2011 |
20120190618 | METHOD AND PHARMACEUTICAL COMPOSITIONS FOR TRANS-BUCCAL MUCOSA TREATMENT OF POSTPRANDIAL HYPERGLYCAEMIA IN TYPE II DIABETES - The invention provides a method and a pharmaceutical composition in the form of a hydroalcoholic solution in which at least one hypoglycemia-inducing/insulinotropic active principle is dissolved in a stable and complete manner at a dosage that is reduced by 30% to 50% compared with the usual oral unit dosage, for its trans-buccal mucosal application in the spot treatment of postprandial hyperglycemia in type II diabetes in man or animals. The invention also pertains to a method of preparing said formulation and to its specific use in the spot treatment of postprandial hyperglycemia (PPHG) in the context of type II diabetes. | 07-26-2012 |
20130248480 | DEVICE FOR PACKAGING, STORING, AND EXTEMPORANEOUSLY PREPARING A PLURALITY OF ACTIVE PRINCIPLES - A device for packaging, conserving, and extemporaneously preparing a plurality of active principles, including a reservoir having a compartment for containing a volume of liquid, the reservoir including a neck defining a dispenser opening; a head that is movable relative to the reservoir between a first distal position for conservation and a second proximate position for preparation; a leaktight closure mechanism; and a rupture mechanism for rupturing the closure mechanism. The closure mechanism is formed by a blister that contains at least two active principles and has at least two compartments, each compartment containing an active principle. The blister is fastened on the neck of the reservoir so as to close it, such that after opening the blister by the rupture mechanism, the active principles enter into contact with the liquid and dissolve therein. | 09-26-2013 |